Madison, WI, United States of America

Kenneth A Bradley


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Location History:

  • Madison, WI (US) (2006 - 2008)
  • Santa Monica, CA (US) (2010)

Company Filing History:


Years Active: 2006-2010

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Kenneth A. Bradley

Introduction

Kenneth A. Bradley is a notable inventor based in Madison, Wisconsin. He has made significant contributions to the field of biotechnology, particularly in the development of antitoxins for anthrax. With a total of three patents to his name, his work has implications for both human and animal health.

Latest Patents

One of his latest patents focuses on anthrax antitoxins. This invention provides compositions that are useful in preparing and serving as antitoxins against the causative agent of anthrax. It includes polypeptides and polynucleotides related to the capillary morphogenesis gene 2 (CMG-2), as well as vectors and host cells containing these molecules. The invention also outlines methods for identifying molecules that bind CMG-2 and those that reduce the toxicity of anthrax toxin. Another patent relates to mammalian anthrax toxin receptor polypeptides and polynucleotides encoding them. This invention also includes methods for identifying molecules that bind the anthrax toxin receptor and reduce its toxicity.

Career Highlights

Kenneth has worked with prominent organizations such as the Wisconsin Alumni Research Foundation and Harvard College. His career has been marked by a commitment to advancing research in the field of anthrax treatment and prevention.

Collaborations

Throughout his career, Kenneth has collaborated with notable individuals, including John A. T. Young and R. John Collier. These collaborations have contributed to the depth and impact of his research.

Conclusion

Kenneth A. Bradley's innovative work in developing antitoxins for anthrax showcases his dedication to improving health outcomes. His patents reflect a significant advancement in biotechnology, with potential benefits for both humans and animals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…